Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
4
94 results
A Europe-wide appraisal of national guidelines for AOM
01-06-2021
National guidelines for the management of acute otitis media (AOM) play a vital role in antibiotic stewardship (ABS). This review evaluates European guidelines for AOM in children based on methodological quality, Strength of Recommendations and consideration of ABS. While major similarities were found, the authors encourage development of centrally produced, locally adapted AOM guidelines to reduce unnecessary administration of antibiotics.
When are antibiotics appropriate in ARS?
01-06-2021
In North America, acute rhinosinusitis (ARS) is a major driver of antibiotic consumption. Prescribers are encouraged to revisit diagnostic criteria for acute bacterial rhinosinusitis (ABRS) when evaluating patients with ARS, to help identify those who require antibiotics, and prescribe the most appropriate antibiotic treatment.
Developing quality indicators to improve quality of care in ABRS
01-06-2021
Quality indicators (QIs) are an initial step toward improving the quality of care provided to patients. Acute bacterial rhinosinusitis (ABRS), a complication of upper respiratory tract infections (URTIs), lacks specifi c QIs. This study proposes 7 ABRS specific QIs to evaluate the diagnosis and management that reduces symptoms, improves quality of life, and prevents complications.
Evaluating Antibiotics commonly prescribed in paediatric CA-RTIs
01-06-2021
Acute otitis media (AOM), acute bacterial rhinosinusitis (ABRS) and the lower respiratory tract infection, community-acquired pneumonia (CAP), are often treated with antibiotics. This paper evaluates the pharmacological properties of the preferred agents, amoxicillin and amoxicillin + clavulanic acid, compared with oral cephalosporins also prescribed in AOM, ABRS, and CAP. The analysis revealed that oral cephalosporins provide unnecessarily broad spectra of activity.
A Europe-wide appraisal of national guidelines for AOM
01-06-2021
National guidelines for the management of acute otitis media (AOM) play a vital role in antibiotic stewardship (ABS). This review evaluates European guidelines for AOM in children based on methodological quality, Strength of Recommendations and consideration of ABS. While major similarities were found, the authors encourage development of centrally produced, locally adapted AOM guidelines to reduce unnecessary administration of antibiotics.
When are antibiotics appropriate in ARS?
01-06-2021
In North America, acute rhinosinusitis (ARS) is a major driver of antibiotic consumption. Prescribers are encouraged to revisit diagnostic criteria for acute bacterial rhinosinusitis (ABRS) when evaluating patients with ARS, to help identify those who require antibiotics, and prescribe the most appropriate antibiotic treatment.
Developing quality indicators to improve quality of care in ABRS
01-06-2021
Quality indicators (QIs) are an initial step toward improving the quality of care provided to patients. Acute bacterial rhinosinusitis (ABRS), a complication of upper respiratory tract infections (URTIs), lacks specifi c QIs. This study proposes 7 ABRS specific QIs to evaluate the diagnosis and management that reduces symptoms, improves quality of life, and prevents complications.
Evaluating Antibiotics commonly prescribed in paediatric CA-RTIs
01-06-2021
Acute otitis media (AOM), acute bacterial rhinosinusitis (ABRS) and the lower respiratory tract infection, community-acquired pneumonia (CAP), are often treated with antibiotics. This paper evaluates the pharmacological properties of the preferred agents, amoxicillin and amoxicillin + clavulanic acid, compared with oral cephalosporins also prescribed in AOM, ABRS, and CAP. The analysis revealed that oral cephalosporins provide unnecessarily broad spectra of activity.
Homepage
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
Sitemap
GlaxoSmithKline (GSK) UK healthcare professional website site map.
Anoro vs. Tiotropium
Anoro vs. Tiotropium
Head to Head Anoro vs tiotropium
Only Anoro has positive head-to-head data vs. Spiolto
Search Results
GlaxoSmithKline (GSK) UK healthcare professional website search results.
Ancillary structural
An overview of clinical data for Anoro Ellipta (umeclidinium/vilanterol).
GSK Updates
Anti-Infectives | Augmentin | Bacterial Infection - GSK Updates in Antimicrobial Resistance
Expert Videos
GSK Vaccines Expert Videos
No results. Why not try:
- Checking the spelling of the search term
- Trying a different search term
- Resetting or revising the filter settings (if you used filters to do this search)
show more
